Ferguson, 70, was also named chairman of Red Cell’s investment committee and appointed to its board, the Washington-based firm said Wednesday in a
Red Cell’s portfolio includes startups that harness artificial intelligence “in the quest to cure cancer and diabetes” and those that use blockchain technology to strengthen communications platforms, Ferguson said in the statement.
In November, less than a month ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
